Medicare Enrolled
Dr. Mohammed Abusamieh, M.D
Rheumatology · Toledo, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Abusamieh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abusamieh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Abusamieh
Dr. Mohammed Abusamieh is a rheumatology specialist in Toledo, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Abusamieh performed 54,185 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Abusamieh received a total of $7,878 from 42 pharmaceutical and/or device companies across 443 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Abusamieh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 10% volume in OH
$7,878 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗54,185
Medicare services
Top 10% in OH for rheumatology
Not available
Unique patients (not deduplicated)
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
25,100 | $11 | $49 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
9,250 | $30 | $75 |
| Denosumab injection (Prolia/Xgeva) | 8,460 | $18 | $33 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
7,750 | $26 | $165 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,222 | $83 | $208 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
596 | $5 | $12 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
430 | $90 | $253 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
395 | $8 | $10 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
193 | $19 | $54 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
170 | $10 | $48 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
156 | $49 | $139 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
108 | $35 | $119 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
59 | $11 | $42 |
| Knee X-ray, 4 or more views An imaging test using X-rays to create multiple pictures of the knee joint from different angles. |
47 | $32 | $72 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
38 | $21 | $48 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
37 | $114 | $320 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
33 | $39 | $136 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
33 | $4 | $12 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
27 | $24 | $53 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
26 | $26 | $66 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
20 | $24 | $54 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
19 | $54 | $141 |
| New patient office visit, complex (60-74 min) | 16 | $138 | $403 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
78.5% high complexity
17.9% medium
3.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,878
Total received (2018-2024)
Avg $1,125/year across 7 years
Top 31% in OH for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
443
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,139
2023
$1,287
2022
$931
2021
$874
2020
$338
2019
$1,519
2018
$1,790
Payments by company (2024)
Amgen Inc.
$295
Janssen Biotech, Inc.
$139
Novartis Pharmaceuticals Corporation
$92
ABBVIE INC.
$90
PFIZER INC.
$84
UCB, Inc.
$78
AstraZeneca Pharmaceuticals LP
$69
E.R. Squibb & Sons, L.L.C.
$60
GlaxoSmithKline, LLC.
$39
Alexion Pharmaceuticals, Inc.
$26
Organon Llc
$24
Lilly USA, LLC
$22
GENZYME CORPORATION
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Fresenius Kabi USA, LLC
$21
Genentech USA, Inc.
$20
Mallinckrodt Hospital Products Inc.
$19
Radius Health, Inc.
$18
Top 3 companies account for 46.2% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,140
Novartis Pharmaceuticals Corporation
$831
PFIZER INC.
$696
AbbVie Inc.
$692
Janssen Biotech, Inc.
$612
AbbVie, Inc.
$430
ABBVIE INC.
$346
GlaxoSmithKline, LLC.
$292
UCB, Inc.
$272
E.R. Squibb & Sons, L.L.C.
$259
Lilly USA, LLC
$249
AstraZeneca Pharmaceuticals LP
$229
Genentech USA, Inc.
$222
Regeneron Healthcare Solutions, Inc.
$215
Horizon Therapeutics plc
$137
Horizon Pharma plc
$133
La Jolla Pharmaceutical Company
$110
Antares Pharma, Inc.
$102
Radius Health, Inc.
$97
Mallinckrodt Hospital Products Inc.
$77
Janssen Scientific Affairs, LLC
$73
Celgene Corporation
$70
GENZYME CORPORATION
$59
Alexion Pharmaceuticals, Inc.
$51
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$45
Organon LLC
$42
Fresenius Kabi USA, LLC
$40
Hikma Pharmaceuticals USA
$39
Aurinia Pharma U.S., Inc.
$38
Merck Sharp & Dohme Corporation
$30
Sebela Pharmaceuticals Inc.
$27
Organon Llc
$24
Mallinckrodt Enterprises LLC
$23
Mallinckrodt LLC
$20
Exeltis, USA Inc.
$18
Bioventus LLC
$18
Ultragenyx Pharmaceutical Inc.
$17
ASSERTIO THERAPEUTICS, Inc.
$16
Orthogenrx Inc.
$14
FIDIA PHARMA USA INC.
$14
Abbott Laboratories
$14
Top 3 companies account for 33.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Axium INS DRG IPG · BENLYSTA · Bimzelx · COLOGUARD DNA CAPTURE REAGENTS · COSENTYX · CYLTEZO · Cimzia · Crysvita · Durolane · EVENITY · EVUSHELD · Enbrel · FORTEO · GIAPREZA · GenVisc 850 · HADLIMA · HUMIRA · HYALGAN · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · LUPKYNIS · LYRICA · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORENCIA · OTREXUP · Otezla · Otrexup · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RIDAURA · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · XELJANZ · XIFAXAN · Zipsor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
14
County median income
$60,095
Nearest hospital to ZIP centroid (approximate)
PROMEDICA TOLEDO HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Abusamieh is a mixed practice specialist, with above-average Medicare volume (top 10% in OH), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Abusamieh experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Abusamieh performed 25,100 golimumab infusion (simponi aria) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Abusamieh receive payments from pharmaceutical companies?
Yes. Dr. Abusamieh received a total of $7,878 from 42 companies across 443 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abusamieh's costs compare to other rheumatologists in Toledo?
Dr. Abusamieh's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abusamieh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Toledo
Browse rheumatologists in Toledo ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in OH
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in OH
Which OH rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology